{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2017", "item": "https://www.patentleaderboard.com/2017/"}, {"@type": "ListItem", "position": 3, "name": "Morphosys Ag", "item": "https://www.patentleaderboard.com/2017/company/morphosys-ag"}, {"@type": "ListItem", "position": 4, "name": "Mark Winderlich", "item": "https://www.patentleaderboard.com/2017/inventor/fl:ma_ln:winderlich-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MW

Mark Winderlich — 1 Patent in 2017

MAMorphosys Ag: 1 patents #7 of 24Top 30%
Munich, DE: #369 of 1,182 inventorsTop 35%
Overall (2017): #313,582 of 506,227Top 65%
1 Patents 2017

Issued Patents 2017

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDate
9765152 Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib Lisa Rojkjaer, Rainer Boxhammer, Jan Endell, Christofer Samuelsson 2017-09-19